Clinical Trial Results for Hypercalcemia

2 Clinical Trials for Hypercalcemia

Focus your search

      RECRUITING
      Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria
      Description

      This study evaluates the efficacy of rifampin in the treatment of hypercalcemia and/or hypercalciuria in participants with at least one inactivating mutation of the CYP24A1 gene. Eligible subjects will receive rifampin for a total of 16 weeks during this study.

      Conditions
      Idiopathic Infantile Hypercalcaemia - Severe FormGenetic DiseaseHypercalcemia, Idiopathic, of InfancyHypercalciuric HypercalcemiaIdiopathic Infantile Hypercalcemia - Mild FormHypercalciuria
      Talk to us
      RECRUITING
      Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity
      Description

      Patients with biochemically confirmed primary hyperparathyroidism and non-localizing SPECT-CT exam within the past year will be included. Subjects will be treated with calcitonin to lower calcium levels immediately prior to reimaging. The goal of this study is to determine whether lowering calcium will improve uptake/retention of sestamibi and improve sensitivity of SPECT-CT to localize parathyroid adenoma.

      Conditions
      Primary HyperparathyroidismHypercalcemia
      Talk to us